Sign inGet started

Guenther Sven

Insider CIK 1638368 · KMPH Exec VP R&D

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZVRA ZEVRA THERAPEUTICS, INC. A Award deriv2024-01-312024-02-0279,000— $079,000SEC↗
KMPH KEMPHARM, INC A Award deriv2023-01-092023-01-11306,000— $0306,000SEC↗
KMPH KEMPHARM, INC A Award deriv2022-02-012022-02-0383,486— $083,486SEC↗
KMPH KEMPHARM, INC A Award deriv2021-08-202021-08-2481,716— $081,716SEC↗
KMPH KEMPHARM, INC A Award deriv2020-02-052020-02-07160,000— $0160,000SEC↗
KMPH KEMPHARM, INC A Award deriv2019-11-252019-11-2756,000— $056,000SEC↗
KMPH KEMPHARM, INC A Award deriv2019-02-062019-02-08160,000— $0160,000SEC↗
KMPH KEMPHARM, INC A Award deriv2018-01-252018-01-2975,000— $075,000SEC↗
KMPH KEMPHARM, INC A Award deriv2017-01-272017-01-3175,000— $075,000SEC↗
KMPH KEMPHARM, INC A Award deriv2016-02-112016-02-1650,000— $050,000SEC↗
KMPH KEMPHARM, INC A Award deriv2015-09-042015-09-0950,000— $050,000SEC↗
KMPH KEMPHARM, INC C Conversion deriv2015-04-212015-04-2126,355— $00SEC↗
KMPH KEMPHARM, INC C Conversion deriv2015-04-212015-04-2116,129— $00SEC↗
KMPH KEMPHARM, INC C Conversion deriv2015-04-212015-04-21136,410— $00SEC↗
KMPH KEMPHARM, INC C Conversion2015-04-212015-04-2123,852— $043,852SEC↗